Comeback From Long coursE Androgen Deprivation Therapy (ADT) With RElugolix and Darolutamide (CLEARED)
Clinical trial NCT06463457 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06463457
- Sponsor
- Atish Choudhury, MD
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-13
- Primary completion
- 2028-11-30
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.